Botanix Pharmaceuticals Limited (ASX: BOT)
Australia
· Delayed Price · Currency is AUD 0.365
-0.025 (-6.41%)
Dec 20, 2024, 4:10 PM AEST
Botanix Pharmaceuticals Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2016 |
| Net Income | -13.87 | -13.87 | -9.15 | -13.17 | -3.33 | -16.73 | Upgrade
|
| Depreciation & Amortization | 0.07 | 0.07 | 0.11 | 0.14 | 0.09 | 0.1 | Upgrade
|
| Stock-Based Compensation | 4.39 | 4.39 | 1.52 | 0.33 | 0.57 | 2.33 | Upgrade
|
| Other Operating Activities | - | - | -0 | - | - | - | Upgrade
|
| Change in Accounts Receivable | -2.34 | -2.34 | -0.41 | -0.1 | 0.09 | 0.35 | Upgrade
|
| Change in Inventory | 1.68 | 1.68 | -0.1 | -3.04 | - | - | Upgrade
|
| Change in Accounts Payable | 1.94 | 1.94 | -4.04 | 4.65 | -0.38 | -3.41 | Upgrade
|
| Operating Cash Flow | -8.13 | -8.13 | -12.07 | -11.18 | -2.97 | -17.36 | Upgrade
|
| Capital Expenditures | -0.11 | -0.11 | -0.01 | -0.01 | -0.01 | -0.09 | Upgrade
|
| Sale (Purchase) of Intangibles | -17.89 | -17.89 | -7.05 | -2.91 | - | - | Upgrade
|
| Other Investing Activities | - | - | - | - | - | -0.06 | Upgrade
|
| Investing Cash Flow | -18 | -18 | -7.05 | -2.92 | -0.01 | -0.15 | Upgrade
|
| Short-Term Debt Issued | - | - | 1.85 | - | - | - | Upgrade
|
| Total Debt Issued | - | - | 1.85 | - | - | - | Upgrade
|
| Short-Term Debt Repaid | - | - | -1.85 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | - | -0.12 | -0.15 | -0.13 | -0.02 | Upgrade
|
| Total Debt Repaid | - | - | -1.97 | -0.15 | -0.13 | -0.02 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | -0.12 | -0.15 | -0.13 | -0.02 | Upgrade
|
| Issuance of Common Stock | 100.85 | 100.85 | 23.59 | - | - | 40.49 | Upgrade
|
| Other Financing Activities | -5.76 | -5.76 | -1.44 | - | - | -3.16 | Upgrade
|
| Financing Cash Flow | 95.1 | 95.1 | 22.03 | -0.15 | -0.13 | 37.31 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.09 | 0.09 | 0.06 | -0.01 | 0.01 | 0.14 | Upgrade
|
| Net Cash Flow | 69.06 | 69.06 | 2.96 | -14.27 | -3.09 | 19.94 | Upgrade
|
| Free Cash Flow | -8.24 | -8.24 | -12.08 | -11.19 | -2.98 | -17.45 | Upgrade
|
| Free Cash Flow Margin | -398.17% | -398.17% | -320.27% | -406.24% | -43.22% | -230.38% | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.00 | -0.02 | Upgrade
|
| Cash Interest Paid | - | - | 0.08 | 0.04 | 0.06 | 0.05 | Upgrade
|
| Cash Income Tax Paid | - | - | -3.67 | -2.75 | -6.88 | -7.56 | Upgrade
|
| Levered Free Cash Flow | -20.3 | -20.3 | -15.57 | -9 | -1.78 | -11.1 | Upgrade
|
| Unlevered Free Cash Flow | -20.3 | -20.3 | -15.52 | -8.97 | -1.74 | -11.07 | Upgrade
|
| Change in Net Working Capital | -1.98 | -1.98 | 4.39 | -1.71 | 0.29 | 2.98 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.